📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Receptos

1.1 - Company Overview

Receptos Logo

Receptos

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of drug discovery, development and commercialization of therapeutics for immune disorders, leveraging pioneering G protein-coupled receptor (GPCR) technology to facilitate information-driven drug design for best- and first-in-class drugs.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Receptos

BioAtla Logo

BioAtla

HQ: United States Website
  • Description: Provider of conditionally active biologics (CABs) for cancer-targeted therapeutics activated under specific physiological conditions; the CIAO! platform for antibody optimization; CAB-ADCs, CAB-CAR-T, and CAB-Bispecifics to improve safety and efficacy; and Mecbotamab Vedotin, a CAB-AXL-ADC for AXL-expressing tumors evaluated in sarcoma and NSCLC.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BioAtla company profile →
Natrogen Therapeutics Logo

Natrogen Therapeutics

HQ: United States Website
  • Description: Provider of Natura-alpha, a small-molecule oral compound undergoing clinical trials for patients with ulcerative colitis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Natrogen Therapeutics company profile →
Phenex Pharmaceuticals Logo

Phenex Pharmaceuticals

HQ: Germany Website
  • Description: Provider of drug discovery and development focused on novel pharmaceuticals, leveraging small-molecule expertise. Privately held, founded in 2002, with Biology and Chemistry laboratories and offices in the Biotech Cluster Rhine-Neckar, primarily in Heidelberg and partly in Ludwigshafen.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Phenex Pharmaceuticals company profile →
Upstream Bio Logo

Upstream Bio

HQ: United States Website
  • Description: Provider of antibody therapies targeting the TSLP receptor, developing verekitug (UPB-101), a monoclonal antibody in Phase 2 trials for severe asthma and chronic rhinosinusitis with nasal polyps (CRSwNP), and conducting research on Thymic Stromal Lymphopoietin (TSLP) as a driver of inflammatory responses in allergic and inflammatory diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Upstream Bio company profile →
Santa Ana Bio Logo

Santa Ana Bio

HQ: United States Website
  • Description: Provider of precision immunology drug development for autoimmune and inflammatory diseases, using single-cell genomics and advanced analytics to develop drugs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Santa Ana Bio company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Receptos

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Receptos

2.2 - Growth funds investing in similar companies to Receptos

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Receptos

4.2 - Public trading comparable groups for Receptos

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Receptos

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Receptos

What does Receptos do?

Receptos is a provider of drug discovery, development and commercialization of therapeutics for immune disorders, leveraging pioneering G protein-coupled receptor (GPCR) technology to facilitate information-driven drug design for best- and first-in-class drugs.

Who are Receptos's competitors?

Receptos's competitors and similar companies include BioAtla, Natrogen Therapeutics, Phenex Pharmaceuticals, Upstream Bio, and Santa Ana Bio.

Where is Receptos headquartered?

Receptos is headquartered in United States.

How many employees does Receptos have?

Receptos has 1,000 employees 🔒.

When was Receptos founded?

Receptos was founded in 2010 🔒.

What sector and industry vertical is Receptos in?

Receptos is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Receptos

Who are the top strategic acquirers in Receptos's sector and industry

Top strategic M&A buyers and acquirers in Receptos's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Receptos?

Top strategic M&A buyers groups and sectors for Receptos include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Receptos's sector and industry vertical

Which are the top PE firms investing in Receptos's sector and industry vertical?

Top PE firms investing in Receptos's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Receptos's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Receptos's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Receptos's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Receptos include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Receptos's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Receptos?

The key public trading comparables and valuation benchmarks for Receptos include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Receptos for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Receptos with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Receptos's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Receptos with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Receptos's' sector and industry vertical?

Access recent funding rounds and capital raises in Receptos's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Receptos